Using Prazosin to Treat Posttraumatic Stress Disorder and Associations: A Systematic Review
Henrique Soares Paiva, Idiberto José Zotarelli Filho, Carlos Filinto da Silva Cais
Psychiatry Investig. 2021;18(5):365-372.   Published online 2021 May 14     DOI: https://doi.org/10.30773/pi.2020.0411
Memory reconsolidation impairment using the β-adrenergic receptor blocker propranolol reduces nightmare severity in patients with posttraumatic stress disorder: a preliminary study
Claire Mallet, Christina F. Chick, Redwan Maatoug, Philippe Fossati, Alain Brunet, Bruno Millet
Journal of Clinical Sleep Medicine.2022; 18(7): 1847.     CrossRef
Case report: Prazosin augmentation for treating comorbid treatment-resistant depression and chronic post-traumatic stress disorder
Ping Guo, Yu Fang, Ming Feng, Xudong Zhao, Shikai Wang, Mincai Qian, Juanjuan Huang, Huanxin Chen
Frontiers in Psychiatry.2022;[Epub]     CrossRef